1 signed distribution agreement (LLP Technokaz ELMI). Clean SIAC dispute clause. Cross-portfolio question: Russia Vet Zoo Clause 15.2 names a different Kazakh entity (TEHNOKAZ-ELIMP, BIN 990340009573) — reconcile to avoid territorial overlap.
Country profile
Kazakhstan — regulatory context
Vet drug authority
Committee of Veterinary Control under Ministry of Agriculture.
EAEU overlay
Kazakhstan is an EAEU member; veterinary pharmaceuticals fall under EAEU Technical Regulations (TR EAEU 043/2017 for medicines). Single registration in one EAEU member state may facilitate mutual recognition in others (Russia, Belarus, Armenia, Kyrgyzstan).
Sanctions exposure
Central Asian banks (Kazakhstan, Kyrgyzstan, Tajikistan) used as last-mile correspondent banking hubs for Russia. Enhanced financial-compliance diligence required if counterparty has Russian ownership or operates via Central Asian banking corridors.
Multi-distributor permissibility
YES Kazakhstan permits multi-distributor; 2026 platform reporting rules and goods registration requirements do not create a blanket exclusivity regime. Subject to competition-law scrutiny.
Voidance risks
Language law: Kazakh OR Russian required for state-court proceedings; foreign-language contracts require certified translation.
NCG (National Commodity Goods) registry: Mandatory for all goods sold in Kazakhstan as of 2026 — non-registration voids sales.
FX controls (CRITICAL): Resolution 22 August 2024 (effective 1 Jan 2025) requires currency-agreement submission for transactions > USD 50,000 equivalent.
Commercial registry filing: Entity registration required; not contract-specific.
Stamp duty / apostille: Apply to cross-border contracts; Kazakhstan is Hague Apostille member.
Standard Vaksindo — reclassified hybrid (BANI applying SIAC Rules) under rebalanced rubric
Counterparty BIN
990340009573 (Kazakhstan business registry confirmed)
Director
Lyudmila Kim (Director)
Term end
31 December 2029 (5-year initial, auto-renewal on 60-day notice)
Top 3 issues
HYBRID dispute clause (BANI applying SIAC Rules) — reclassified from CLEAN under rebalanced rubric.
Both signature dates BLANK on witness page.
Russia Vet Zoo Cl. 15.2 names same entity as Russia's downstream sub-distributor — cross-portfolio conflict.
Authorized Products (current LOA)
LOA signed 27 March 2025, valid until 27 March 2030 (5-year authorization). 12 SKUs covered.
#
Product
Strain
Dose
1
VAKSIMUNE ND L5
Lasota (L5)
1000 ds
2
VAKSIMUNE ND B1
B1
1000 ds
3
VAKSIMUNE IB
Mass H120
1000 ds
4
VAKSIMUNE IB GX
GX (Chinese IB variant)
1000 ds
5
VAKSIMUNE IB NV-1
Mass + variant
1000 ds
6
VAKSIMUNE IBD L
intermediate-mild IBD
1000 ds
7
VAKSIMUNE IBD M+
intermediate-plus IBD
1000 ds
8
VAKSIMUNE CAV
Chicken Anemia Virus
1000 ds
9
VAKSIMUNE ND L Multi
ND multi-strain inactivated
1000 ds
10
VAKSIMUNE NDL Multi IBPlus EDS
ND-L + IB + EDS inactivated
1000 ds
11
VAKSIMUNE CORYZA COLI
Avibacterium paragallinarum + E. coli
1000 ds
12
VAKSIMUNE NDL Inakti 0,1
ND-Lasota inactivated 0.1 ml
5000 ds
Country watch items
Cross-portfolio counterparty conflict
Russia Vet Zoo Clause 15.2 names TEHNOKAZ-ELIMP, BIN 990340009573 as Kazakhstan distributor.
JAPFA's Kazakhstan-Technokaz signed agreement is with LLP Technokaz ELMI (different BIN). Verify TEHNOKAZ-ELIMP's existence + non-SDN status. Reconcile with JAPFA's existing Kazakhstan-Technokaz relationship to avoid territorial overlap or counterparty conflict. See Russia file.
Suggested actions low priority
Open items
Add signature dates on witness page (both BLANK).
Verify Schedule A duplicate row "ND L Multi IBPlus EDS".
Cross-portfolio: verify TEHNOKAZ-ELIMP (BIN 990340009573) named in Russia Vet Zoo Clause 15.2 — distinguish from this contract.